Awards & Recognition - VIVOS INC. (formerly AMIC) has been recognized as a leader by local, state and federal agencies.
• $1.3 million U.S. Federal grant for brachytherapy
• Leaders in Healthcare Award, Seattle Business Magazine
• Federal Laboratory Consortium Award for Excellence in Technology Transfer,
a prestigious honor recognized by the US Secretary of Energy and US Senator Murray
2015 - AMIC awarded $250,000 Life Sciences Discovery Fund Grant as Commercialization Partner
Focus: To test a novel technology for delivering high-dose radiation to solid cancers that cannot be removed surgically
Anticipated Impact: Safer, more effective treatment of radiation-resistant solid cancers
August 3, 2013 - The Secretary of Energy, Washington, D.C.
RadioGel™ is a hydrogel liquid containing tiny yttrium-90 phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.
